VIE/BAVA (VIE/BAVA)

Vienna Stock Exchange: VIE/BAVA · EUR

€32.9

-1.32 (-3.9%)· Recorded snapshot

Market cap	2.5B
Revenue (ttm)	847.8M
Net income (ttm)	206.3M
EPS (ttm)	€2.60
P/E (trailing)	12.7x
P/E (forward)	19.7x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 847.8M
Net income (ttm): 206.3M
EPS (ttm): €2.60
P/E (trailing): 12.7x
P/E (forward): 19.7x
Market cap: 2.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 19:55 UTC

Forward P/E19.7

P25 n/aP50 n/aP75 n/a

Trailing P/E12.7

P25 n/aP50 n/aP75 n/a

ROE12.2

P25 n/aP50 n/aP75 n/a

ROIC8.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/BAVA indicators

Market & fundamental data

Available fields

218

Groups with data

Currency

DKK

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Denmark
Country code	AT
Earnings date	2026-11-13
Employees	1,906
Employees change	87
Employees growth	5.42%
Enterprise value	EUR 2.2B
Exchange	Vienna Stock Exchange
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1992
Industry	Biotechnology
Is primary listing	No
ISIN number	DK0015998017
Last earnings date	2026-08-21
Last refreshed	2026-10-30
Market cap	EUR 2.5B
Next earnings date	2026-11-13
Price	EUR 32.90
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/BAVA
Website	https://www.bavarian-nordic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	12.24x
Average P/E ratio (5Y)	15.12x
Earnings yield	7.9%
EV/Earnings	10.72x
EV/EBIT	14.42x
EV/EBITDA	9.13x
EV/FCF	13.35x
EV/Sales	2.61x
FCF / EV yield	7.49%
FCF yield	6.6%
Forward P/E	19.73x
Graham number	37.55829
Graham upside	14.16%
Lynch fair value	EUR 34.50
Lynch upside	4.85%
P/(FCF - SBC) ratio	16.36x
P/(OCF - SBC) ratio	13.94x
P/B ratio	1.42x
P/E ratio	12.66x
P/FCF ratio	15.15x
P/OCF ratio	13.05x
P/S ratio	2.96x
Price / tangible book value	2.53x
Price/EBITDA ratio	10.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.09%
EBITDA margin	28.12%
Effective tax rate	22.13%
FCF margin	19.54%
Gross margin	50.22%
Operating margin	18.09%
Pretax margin	31.26%
Profit margin	24.34%
Profit per employee	EUR 108,257
Profitable quarters	2
Profitable years	3
Revenue per employee	EUR 444,784
ROA	5.01%
ROA (5Y)	3.34%
ROCE	8.37%
ROE	12.21%
ROE (5Y)	4.99%
ROIC	8.3%
ROIC (5Y)	8.22%
SBC / revenue	1.45%
Tax / revenue	6.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	8.06%
EPS growth (Q)	169.7%
EPS growth (QoQ)	4,350%
EPS growth 3Y	9.6%
EPS growth quarters	1
EPS growth years	1
FCF growth	-26.02%
FCF growth (Q)	-72.84%
FCF growth 3Y	67.11%
Gross profit growth	-7.14%
Gross profit growth (Q)	34.77%
Gross profit growth 3Y	-4.85%
Gross profit growth 5Y	44.25%
Net income growth	8.44%
Net income growth (Q)	101.79%
Net income growth (QoQ)	4,215.71%
Net income growth 3Y	12.75%
Net income growth quarters	1
Net income growth years	1
OCF growth	-18.59%
OCF growth (Q)	-72.36%
OCF growth 3Y	36.33%
Operating income growth	-26.06%
Operating income growth (Q)	101.84%
Operating income growth 3Y	-2.96%
Revenue growth	-1.82%
Revenue growth (Q)	23.19%
Revenue growth (QoQ)	92.32%
Revenue growth 10Y	28.03%
Revenue growth 3Y	4.63%
Revenue growth 5Y	30.22%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -26.7M
Depreciation and amortization	EUR 85M
EBIT	EUR 153.4M
EBITDA	EUR 238.4M
EPS	EUR 2.60
Financing cash flow	EUR -54.2M
Free cash flow	EUR 165.7M
Free cash flow minus SBC	EUR 153.4M
Gross profit	EUR 425.7M
Income taxes	EUR 58.6M
Investing cash flow	EUR -197.5M
Net borrowing	EUR -5M
Net cash flow	EUR -59.4M
Net income	EUR 206.3M
Operating cash flow minus SBC	EUR 180.1M
Operating income	EUR 153.4M
Revenue	EUR 847.8M
Stock-based compensation	EUR 12.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.58
Book value per share	EUR 23.27
Debt / EBITDA	0.07
Debt / equity	0.01
Debt / FCF	0.11
Interest coverage	134.48
Long-term assets	EUR 1.1B
Long-term liabilities	EUR 64.3M
Net cash (debt)	EUR 297.8M
Net cash / market cap	11.87%
Net cash growth	45.77%
Net debt / EBITDA	-1.25
Net debt / equity	-0.17
Net debt / FCF	-1.8
Piotroski F-Score	5
Property, plant and equipment	EUR 286.7M
Shareholders' equity	EUR 1.8B
Tangible book value	EUR 992.7M
Tangible book value per share	EUR 13.07
Total assets	EUR 2B
Total cash	EUR 315.4M
Total debt	EUR 17.6M
Total liabilities	EUR 201.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	EUR 895.2M
Current liabilities	EUR 137M
Current ratio	6.53
Inventory turnover	1.18
Net working capital	EUR 448.6M
Quick ratio	3.83
Working capital	EUR 757.8M
Working capital turnover	0.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.61%
Shareholder yield	-0.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 26.50
1D price change	-3.86%
1M price change	13.14%
1M total return	13.14%
1W price change	0.67%
1W total return	0.67%
1Y price change	3.95%
1Y return CAGR	3.95%
1Y total return	3.95%
20-day SMA	EUR 31.61
200-day SMA	EUR 26.28
3M price change	37.31%
3M total return	37.31%
3Y price change	86.77%
3Y return CAGR	23.15%
3Y total return	86.77%
50-day SMA	EUR 29.65
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 34.26
52-week high date	2026-10-28
52-week low	EUR 22.96
52-week low date	2026-06-22
6M price change	32.24%
6M total return	32.24%
All-time high	EUR 39.43
All-time high date	2024-08-16
All-time low	EUR 16.97
All-time low date	2023-10-19
Average true range (ATR)	EUR 0.61
Average volume	17.2
Change from 52-week high	-3.97%
Change from 52-week low	43.29%
Change from all-time high	-16.56%
Change from all-time low	93.87%
Change from open	-3.41%
Day's gap	-0.47%
High price	EUR 34.06
Low price	EUR 32.90
Monthly RSI	61.46
Open price	EUR 34.06
Position in 52-week range	0%
Previous close	EUR 34.22
Price vs 150-day SMA	24.13%
Price vs 20-day SMA	4.07%
Price vs 200-day SMA	25.18%
Price vs 50-day SMA	10.95%
Relative volume	13.36
RSI	63.55
Sharpe ratio	0.12
Sharpe ratio (3Y)	0.53
Sortino ratio	0.31
Sortino ratio (3Y)	0.92
Weekly RSI	71.19
YTD price change	28.22%
YTD total return	28.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	75.7M
Shares change (QoQ)	-3.02%
Shares change (YoY)	0.61%
Shares held by insiders	0.06%
Shares held by institutions	33.83%

Deeper analysis on VIE/BAVA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/BAVA report

Is a complete VIE/BAVA research report available?

No complete published report is available for vie/BAVA (VIE/BAVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/BAVA (VIE/BAVA)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/BAVA

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/BAVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/BAVA

Frequently asked questions